Patents by Inventor Amar Sharma

Amar Sharma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11123358
    Abstract: The present invention relates to a compound for use as a medicament in the treatment or prevention of acute liver failure, which acute liver failure is induced by intoxication prior to or following administration of the compound. Accordingly, the invention relates to the compound for use in the treatment of an intoxication that without treatment is expected to result in acute liver failure or that without treatment is sufficient to induce acute liver failure. The invention also provides the compound for use in the treatment, and a corresponding method for the treatment of an intoxication sufficient to induce acute liver failure.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: September 21, 2021
    Assignee: Medizinische Hochschule Hannover
    Inventors: Amar Sharma, Michael Ott, Tobias Cantz, Dakai Yang
  • Publication number: 20190167713
    Abstract: The present invention relates to a compound for use as a medicament in the treatment or prevention of acute liver failure, which acute liver failure is induced by intoxication prior to or following administration of the compound. Accordingly, the invention relates to the compound for use in the treatment of an intoxication that without treatment is expected to result in acute liver failure or that without treatment is sufficient to induce acute liver failure. The invention also provides the compound for use in the treatment, and a corresponding method for the treatment of an intoxication sufficient to induce acute liver failure.
    Type: Application
    Filed: May 30, 2017
    Publication date: June 6, 2019
    Inventors: Amar SHARMA, Michael OTT, Tobias CANTZ, Dakai YANG
  • Publication number: 20160275592
    Abstract: Systems, methods, and apparatus are disclosed for reserving items of merchandise for in store pickup and/or inspection. In some embodiments, a reservation method for a store includes receiving, from a first computing device associated with a customer, a request to reserve a requested item for the customer. The reservation method may further include identifying, based on the requested item, an additional item to reserve for the customer. The reservation method may also include sending, to a second computing device associated with an employee of the store, a notification that instructs the employee to gather the requested item and the additional item and place the gathered items in a reserved merchandise area of the store.
    Type: Application
    Filed: March 20, 2015
    Publication date: September 22, 2016
    Inventors: Prerna Mamgain, Kartik Swamy, Srinivasa Vanukuri, Amar Sharma
  • Patent number: 9443262
    Abstract: Systems, methods, and apparatus are disclosed for reserving items of merchandise for in store pickup and/or inspection. In some embodiments, a reservation method for a store includes receiving, from a first computing device associated with a customer, a request to reserve a requested item for the customer. The reservation method may further include identifying, based on the requested item, an additional item to reserve for the customer. The reservation method may also include sending, to a second computing device associated with an employee of the store, a notification that instructs the employee to gather the requested item and the additional item and place the gathered items in a reserved merchandise area of the store.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: September 13, 2016
    Assignee: SEARS BRANDS, L.L.C.
    Inventors: Prerna Mamgain, Kartik Swamy, Srinivasa Vanukuri, Amar Sharma
  • Publication number: 20120264805
    Abstract: Small inhibitory RNA (siRNA) molecules, which e.g. are purified and/or isolated, as an active in a medicament, which siRNA molecules are inhibitory RNA molecules that through RNA interference (RNAi) reduce or prevent expression of the p53 upregulated modulator of apoptosis (PUMA). The siRNA molecules can be administered as a medicament to a patient suffering from an impaired liver function or from liver damage for the treatment of a functionally impaired liver, for delaying a deterioration of liver function and/or for prevention of liver failure, especially in patients who suffer from a critical impairment of damage to the liver, e.g. for delaying the complete failure of liver function.
    Type: Application
    Filed: April 15, 2011
    Publication date: October 18, 2012
    Applicant: MEDIZINISCHE HOCHSCHULE HANNOVER
    Inventors: Amar Sharma, Tobias Cantz, Michael Ott, Nidhi Narain